Cell line and uses thereof
CA 2529882 C · Owner: Abbvie Inc. · Inventors: Fry, Dennis G.; Dayton, Brian D.; Collins, Christine A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The subject invention relates to a novel cell line referred to as , T42402I3.4.2, and to uses of this cell line. For example the cell line may be , used in the production of recombinant melanin concentrating hormone (MCH) receptor protein and in the identification of antagonists inverse agonists , and agonists to the receptor.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 15, 2004 and granted May 20, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 15, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 15, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.